Chemotherapy in Treating Patients With Liver Cancer

Status unconfirmed · Phase 2

Conditions studied: Liver Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving drugs in different ways may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of cisplatin and epinephrine administered directly into the tumor in treating patients who have primary liver cancer that cannot be removed during surgery.

Key facts

Study ID

NCT00003044

Run by

Matrix Pharmaceutical

People needed

55

Starts

1996-09-01

Last updated by the study team

2013-12-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Johns Hopkins Oncology Center — Baltimore, Maryland, United States
• Mayo Clinic Cancer Center — Rochester, Minnesota, United States
• Prince of Wales Hospital — Shatin, New Territories, Hong Kong

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.